INS and Hypoglycemia: The ability of GLUCOSE to maintain high performance across diverse clinical scenarios further supports its potential integration into clinical practice, where it could enhance patient outcomes by reducing variability in insulin dosing and minimizing the risks associated with both hyperglycemia and hypoglycemia.